Rymedi

How does Rymedi empower life sciences companies to improve human health? See the video below on how our blockchain-enabled technology supports clinical research for better patient outcomes. Are you a study sponsor or CRO that would like more information? Request a demo today or start the conversation with us. www.rymedi.com/contact-us #clinicalresearch #healthcaretechnology #precisionmedicine #web3 #desci #blockchain #medicalresearch #clinicaltrial David Stefanich, Jason Cross, Elizabeth Yarbrough, Steve Clemons, Scott Bowden, Jim Bickelhaupt, Mark Elfers, Deepak H., Charlie Jordan, Nancy Greer, Armando A., Omar Al Gburi, Aditya Tatipaka, Sergii Babikov, Vi Huynh, Kristina Loughrey, SCbio

Proud to announce a press release of Public Good Pharma's partnership with Rymedi, a pioneer in the Web 3.0 / DeSci space, established by our co-founder Dr Jason Cross. Thank you for your support and guidance over many years ❤️ Let's change the world together by improving access to medicine! ✊🏼 🚀 🦾 Jason Cross David Stefanich Deepak H. Bill Crown Kevin Knopf MD MPH Zan Lowe-Skillern Irni Mark Gemzon #Rymedi #PublicGoodPharma #financialinnovation #blockchain #web3 #DeSci #genericdrugrepurposing #interventionalpharmacoeconomics #affordablemedicine

Hats off to DWF Labs for creating an Ecosystem Summary Chart to keep tract of all the leading companies in the DeSci Ecosystem. Rymedi is proud to be a innovator in Healthcare within the DeSci Ecosystem. If you'd like to learn how we can help you, check out our website at www.Rymedi.com

Rymedi, a leader in clinical data management using blockchain technology, and Public Good Pharma (PGP) a financially-innovative biotech company established by Crowd Funded Cures, a registered charity and early DeSci pioneer, today announced a strategic partnership to revolutionize medicine accessibility. https://lnkd.in/enZRGjtg

Our CEO, David Stefanich spoke at the BRAIN Conference today in London. The BRAIN Conference, dedicated to neurovascular diseases, is where international faculty gathered under one roof to provide education on several topics, including stroke, aneurysms, new technology and much more. David was able to address how our technology at Rymedi can help further advance Clinical Trials and improve security, transparency and collaboration. Learn more about how we are improving healthcare on our website, www.rymedi.com. #Blockchain #Healthcare #Web3 #DeSCI

Our CEO, David Stefanich, has made it to the BRAIN Conference in London this week. If you’re there, please join him as he speaks on Using Blockchain in Clinical Trials on Wednesday at 4:00pm. If you want more information before then, check out our website at www.RYMEDI.com #Blockchain #Healthcare

Our CEO, David Stefanich, has made it to the BRAIN Conference in London this week. If you’re there, please join him as he speaks on Using Blockchain in Clinical Trials on Wednesday at 4:00pm. If you want more information before then, check out our website at www.RYMEDI.com #Blockchain #Healthcare

Rymedi is thankful for the friends and family we have made over this past year! We are grateful to have such a devoted and hard working team who are passionate about changing the healthcare space for the better. #thankful #teamrymedi #healthcare

Rymedi is proud to support the new Veterinary School at Clemson. What a beautiful day for a groundbreaking and dedication. Our continued partnership with Clemson University helps drive better wellness and support our mission to improve global health. David Stefanich Jason Cross Chad Treboniak ,Clemson University Clemson University College of Veterinary Medicine

It's been 6 years since the team was in Mongol improving Global Health. The Onom Foundation helped cure nearly 60,00 people through the study. It was Rymedi's first use case of the technology platform. So glad to be able to reunite in Greenville, SC. and catch up on things. Six years hasn't aged them too much! David Stefanich Jason Cross Dr. ND Dashdorj Onom Jeffrey Bill